SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-045128
Filing Date
2017-07-13
Accepted
2017-07-13 20:33:44
Documents
2
Period of Report
2017-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2744
2 POA DOCUMENT poa.txt EX-24.3_736630 3040
  Complete submission text file 0001209191-17-045128.txt   7176
Mailing Address 1865 PALMER AVE, SUITE 104 LARCHMONT NY 10538
Business Address
GABRIELI CHRISTOPHER (Reporting) CIK: 0001181553 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38137 | Film No.: 17964380

Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Issuer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations